JKphArma

Our products

We develop existing lipophilic active principles under new and patented galenic forms enabling administration via the per-mucous sub-lingual route or the per-mucous gingivo-jugal route, thus allowing their instant systemic bioavailability in order to enhance efficacy, tolerance and acceptability.
Development Strategy

Development Strategy

The strategy of JKphArma Galenic Innovation is based on the rapid development of existing active principles, using new galenic forms enabling...

Read more
Products

Products

Administration via the per-mucous sub-lingual route or the per-mucous gingivo-jugal route, in order to enhance efficacy, tolerance and...

Read more